SARS-CoV-2 is an appropriate name for the new coronavirus

[1]  A. Gorbalenya,et al.  Partitioning the Genetic Diversity of a Virus Family: Approach and Evaluation through a Case Study of Picornaviruses , 2012, Journal of Virology.

[2]  A. Russo,et al.  COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients? , 2020, Frontiers in Oncology.

[3]  Extrapulmonary Gastrointestinal Presentation of Coronavirus (COVID-19): A Case Report and Review of Literature , 2020, Cureus.

[4]  L. Stamatatos,et al.  Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation , 2020, bioRxiv.

[5]  S. Kanj,et al.  Emergence of MERS-CoV in the Middle East: Origins, Transmission, Treatment, and Perspectives , 2014, PLoS pathogens.

[6]  Christian Drosten,et al.  Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group , 2020, bioRxiv.

[7]  H. L. Mavioğlu.  Perioperative planning for cardiovascular operations in the COVID-19 pandemic. , 2019, Turk gogus kalp damar cerrahisi dergisi.

[8]  Wenjie Tan,et al.  A distinct name is needed for the new coronavirus , 2020, The Lancet.

[9]  Andrew J. Davison,et al.  Consensus statement: Virus taxonomy in the age of metagenomics , 2017, Nature Reviews Microbiology.

[10]  A. Laaksonen,et al.  On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2 , 2020, bioRxiv.

[11]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.